ANAHID EBRAHIMI: Open Payments
NPI 1508043944 · HIRAM, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,439 in 73 payments from 18 companies in 2025. Trend: 2023 $1,202 · 2024 $1,273 · 2025 $1,439
Food & beverage: $1,339Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $349 |
| Janssen Biotech, Inc. | 10 | $215 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $111 |
| GENZYME CORPORATION | 5 | $110 |
| QOL Medical, LLC | 3 | $78 |
| Lilly USA, LLC | 3 | $76 |
| Phathom Pharmaceuticals, Inc. | 6 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $51 |
| Ardelyx, Inc. | 2 | $44 |
Products named: TREMFYA, DUPIXENT, LINZESS, XIFAXAN, RINVOQ, Sucraid, OMVOH, ENTYVIO.
Industry payments across GA — which companies pay providers there.
